The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating

Journal of Physiology

Volumn 572, Issue 2, 2006, Pages 347-358

  Cui, Liying ^a   Aleksandrov, Luba ^a   Hou, Yue Xian ^d   Gentzsch, Martina ^b   Chen, Jey Hsin ^d   Riordan, John R ^a   Aleksandrov, Andrei A ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BENZYLMETHANETHIOSULFONIC ACID; CYSTEINE; PHENYLALANINE; SULFONIC ACID DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; THIOL REAGENT;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL MEMBRANE CONDUCTANCE; CHANNEL GATING; CHEMICAL MODIFICATION; CONTROLLED STUDY; GENE MUTATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MOLECULAR INTERACTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FOLDING; BHK CELL LINE; MEMBRANE VESICLE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STABLE EXPRESSION; WILD TYPE;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CHLORIDE CHANNELS; CRICETINAE; CYSTEINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; HYDROLYSIS; ION CHANNEL GATING; MICROSCOPY, FLUORESCENCE; MUTATION; PHENYLALANINE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 33645533055     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.099457     Document Type: Article

References (19)

1. Aleksandrov LA, Aleksandrov AA, Chang X-B & Riordan JR (2002). The first nucleotide binding domain of cystic fibrosis transmembrane conductance regulator is a site of stable nucleotide interaction, whereas the second is a site of rapid turnover. J Biol Chem 277, 15419-15425.
2. Aleksandrov LA, Mengos A, Chang X-B, Aleksandrov AA & Riordan JR (2001). Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 276, 12918-12923.
3. Aleksandrov AA & Riordan JR (1998). Regulation of CFTR ion channel gating by MgATP. FEBS Lett 431, 97-101.
4. Chang X-B, Tabcharani JA, Hou Y-X, Jensen TJ, Kartner N, Alon N, Hanrahan JW & Riordan JR (1993). Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem 268, 11304-11311.
5. Chen EY, Bartlett MC, Loo TW & Clarke DM (2004). The ΔF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 279, 39620-39627.
6. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan C & Smith AE (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834.
7. Colquhoun D & Hawkes AG (1990). Stochastic properties of ion channel openings and bursts in a membrane patch that contains two channels: Evidence concerning the number of channels present when a record containing only single openings is observed. Proc R Soc Lond B Biol Sci 240, 453-477.
8. Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Parvani A, Lecocq J-P & Lazdunski M (1991). 'Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation. Nature 354, 526-528.
9. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE & Welsh MJ (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764.
10. Du K, Sharma M & Lukacs GL (2005). The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struct Mol Biol 12, 17-25.
11. Kopito RR (1999). Biosynthesis and degradation of CFTR. Physiol Rev 79 (Suppl. 1), S167-S173.
12. Lewis HA, Zhao X, Wang C, Sauder JM, Rooney I, Noland BW, Lorimer D, Kearins MC, Conners K, Condon B, Maloney PC, Guggino WB, Hunt JF & Emtage S (2005). Impact of the ΔF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem 280, 1346-1353.
13. Li C, Ramjeesingh M, Wang W, Garami E, Hewryk M, Lee D, Rommens JM, Galley K & Bear CE (1996). ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 271, 28463 -28468.
14. Riordan JR (1999). Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein. Am J Hum Genet 64, 1499-1504.
15. Schultz BD, Frizzell RA & Bridges RJ (1999). Rescue of dysfunctional ΔF508-CFTR chloride channel activity by IBMX. J Membr Biol 170, 51-66.
16. Thibodeau PH, Brautigam CA, Machius M & Thomas PJ (2005). Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol 12, 10-16.
17. Vergani P, Lockless SW, Nairn AC & Gadsby DC (2005). CFTR channel opening by ATP driven tight dimerization of its nucleotide-binding domains. Nature 433, 876-880.
18. Wang F, Zeltwanger S, Hu S & Hwang T-C (2000). Deletion of phenylalanine 508 causes attenuated phosphorylation-dependent activation of CFTR chloride channels. J Physiol 524 3, 637-648.
19. Winter MC, Sheppard DN, Carson MR & Welsh MJ (1994). Effect of ATP concentration on CFTR Cl channels: A kinetic analysis of channel regulation. Biophys J 66, 1398-1408.